This is the threshold associated with bariatric surgery outcomes in published literature
Start your intake Understanding Semaglutide Dosing Schedules Semaglutide treatment begins at a low dose and increases gradually over approximately 16 weeks through a process called titration
10.1038/s41598-021-97967-0 Summary Keywords heart failure, GLP-1, glucagon-like peptide-1, clinical trials, cardiovascular disease, cardiovascular outcome studies, diabetes, obesity Citation Kreiner FF, Hovingh GKK and von Scholten BJ (2022) The potential of glucagon-like peptide-1 receptor agonists in heart failure
Common Side Effects Mild stomach discomfort Nausea Headache Bloating These effects are usually temporary and resolve on their own
Interestingly, this residue is conserved in Class B1 GPCRs, such as glucagon, vasoactive intestinal peptide (VIP), and glucagon-like peptide-1 (GLP-1) (Liu et al., 2025)